How will the new reimbursement chapter and companioning legislative amendments about personalized medicines and their markers affect the reimbursement of our product?

Due to the technological progress in treatment options and diagnosis, a new reimbursement chapter was introduced to simultaneously evaluate medicines and their accompanying markers. If you plan to apply for reimbursement for these type of products, Innosens can help you to prepare and shape your application for this new procedure. If your company already has such a reimbursed product in its portfolio, your product will be transferred into this chapter, which also requires a (short) submission procedure.

Want to know more about this topic?

We make sure we give you the advice you need!